Discover 1,605 paid clinical trials in Newnan, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,605
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Atlanta GA, Birmingham AL, Greenville SC, Knoxville TN,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase3, Recruiting
Use of Repris Needle in Bladder Injection
for
Overactive Bladder Syndrome
Location: Cartersville GA
Sponsor: Uro-1 Medical
Sex: Female
Age: 18+
Code: NCT04982120
Recruiting
Pompe Pregnancy Sub-Registry
for
Glycogen Storage Disease Type II (GSD-II),
Location: Atlanta GA, Greenville SC, Jacksonville FL, Durham NC,
Sponsor: Genzyme, a Sanofi Company
Sex: Female
Age: 0+
Code: NCT00567073
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Location: Atlanta GA, Birmingham AL, Columbia SC, Nashville TN,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Atlanta GA, Montgomery AL, Birmingham AL, Augusta GA,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase2, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Atlanta GA, Birmingham AL, Chattanooga TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
for
Triple Negative Breast Cancer
Location: Atlanta GA
Sponsor: ProDa BioTech, LLC
Sex: All
Age: 18+
Code: NCT06460298
Phase1, Phase2, Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
for
Breast Cancer, Breast Cancer Metastatic,
Location: Atlanta GA, Augusta GA, Charlotte NC, Durham NC,
Sponsor: Incyclix Bio
Sex: All
Age: 18+
Code: NCT05735080
Phase1, Phase2, Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)